Inter-ethnic difference in sparteine oxidation among Ghanaians and Germans
- 1 January 1985
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 28 (1), 79-83
- https://doi.org/10.1007/bf00635712
Abstract
Sparteine oxidation, which exhibits genetic polymorphism in various Caucasian populations, was studied in 154 unrelated Ghanaian subjects. Mean total urinary recovery of sparteine and 2- and 5-dehydrosparteines (56.6±16.6% of the dose) was not different from Caucasians. In contrast to Caucasians, amongst whom 6.3 to 9% of the population are poor metabolizers (PM), no PM subject was observed in the Ghanaian population sample. The data appear to indicate allelic differences between Caucasians and Ghanaians in the gene encoding the synthesis of the P-450 isozyme involved in polymorphic sparteine oxidation.This publication has 27 references indexed in Scilit:
- Purification and characterization of six cytochrome P-450 isozymes from human liver microsomesBiochemistry, 1983
- The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions.Journal of Medical Genetics, 1983
- Ethnic Differences in Drug MetabolismClinical Pharmacokinetics, 1982
- Defective Oxidation of DrugsClinical Pharmacokinetics, 1982
- The polymorphic 4-hydroxylation of debrisoquine in a Saudi arab populationXenobiotica, 1980
- Isolation and purification of cytochrome P-450, and the existence of multiple formsPharmacology & Therapeutics, 1979
- Polymorphisms of Oxidation at Carbon Centers of Drugs and Their Clinical SignificanceDrug Metabolism Reviews, 1979
- A Population and Familial Study of the Defective Alicyclic Hydroxylation of Debrisoquine among EgyptiansXenobiotica, 1979
- Studies on Microbial Transformation. XXVI. Microbial Oxidation of (-)-SparteineCHEMICAL & PHARMACEUTICAL BULLETIN, 1973
- Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compoundsLife Sciences, 1967